The TSC1-2 tumor suppressor controls insulin-PI3K signaling through the regulation of IRS proteins - Evidence review
In mouse cells, loss of TSC1-2 keeps mTOR-S6K overactive and lowers IRS proteins, blunting insulin and IGF-1 signaling. Preclinical evidence.
Authors
- Melania Mondini (ORCID: https://orcid.org/0009-0008-5005-7693)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24335042
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00